These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1370552)

  • 1. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
    Moore M; Teresky AK; Levine AJ; Seiberg M
    J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus.
    Chen J; Tobin GJ; Pipas JM; Van Dyke T
    Oncogene; 1992 Jun; 7(6):1167-75. PubMed ID: 1317542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant.
    Symonds HS; McCarthy SA; Chen J; Pipas JM; Van Dyke T
    Mol Cell Biol; 1993 Jun; 13(6):3255-65. PubMed ID: 8388535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice.
    Feigenbaum L; Hinrichs SH; Jay G
    J Virol; 1992 Feb; 66(2):1176-82. PubMed ID: 1309896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen.
    Marks JR; Lin J; Hinds P; Miller D; Levine AJ
    J Virol; 1989 Feb; 63(2):790-7. PubMed ID: 2642978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.
    Tan TH; Wallis J; Levine AJ
    J Virol; 1986 Sep; 59(3):574-83. PubMed ID: 3016321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
    Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
    Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene.
    Hino O; Kitagawa T; Nomura K; Ohtake K; Cui L; Furuta Y; Aizawa S
    Jpn J Cancer Res; 1991 Nov; 82(11):1226-33. PubMed ID: 1684356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.
    Sáenz Robles MT; Symonds H; Chen J; Van Dyke T
    Mol Cell Biol; 1994 Apr; 14(4):2686-98. PubMed ID: 8139568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.
    Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2910-4. PubMed ID: 7681991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53.
    Zhu JY; Abate M; Rice PW; Cole CN
    J Virol; 1991 Dec; 65(12):6872-80. PubMed ID: 1658380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation.
    Tiemann F; Zerrahn J; Deppert W
    J Virol; 1995 Oct; 69(10):6115-21. PubMed ID: 7666515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53.
    Symonds H; Chen JD; Van Dyke T
    J Virol; 1991 Oct; 65(10):5417-24. PubMed ID: 1895390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes.
    Efrat S; Baekkeskov S; Lane D; Hanahan D
    EMBO J; 1987 Sep; 6(9):2699-704. PubMed ID: 2824189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Haas MJ; Pitot HC
    Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
    Ghebranious N; Knoll BJ; Wu H; Lozano G; Sell S
    Mol Carcinog; 1995 Jun; 13(2):104-11. PubMed ID: 7605578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations.
    Kierstead TD; Tevethia MJ
    J Virol; 1993 Apr; 67(4):1817-29. PubMed ID: 8383212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.